New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Bath & Body Works, Inc.

BBWI

Consumer Cyclical Specialty Retail

Bath & Body Works, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $7.3 billion, roughly unchanged from fiscal 2025.

Revenue
−2.26%
EPS
+93.3%
Free cash flow
n/m
Total debt
−7.05%

Quarter to July 2026, against a year earlier

18.94 0.29 +1.55%
Market cap
$3.8B
P/E
4.9×
Fwd P/E FY27e
7.1×
Dividend yield
4.29%
F-score
6/9
ROIC
42.7%
Net debt / EBITDA
2.1×
Payout ratio
0.2×

Ratios over time Q3 FY26 to Q2 FY27

Returns on capital

ROIC was 42.7% in Q2 FY27, against a low of 36.5% in Q3 FY26.

ROEROIC
Q3 FY26Q4 FY26Q1 FY27Q2 FY27
ROE−41.9%−48.8%−56.3%−60.0%
ROIC36.5%42.4%43.2%42.7%

Debt

Net debt is 10.25× a year’s EBITDA.

Net debt / EBITDA
Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Net debt / EBITDA16.3×4.4×9.6×10.3×

Cash cycle, in days

Customers pay in 8 days, inventory is held 80 days and suppliers are paid in 61. Cash is tied up for 27 days between paying for goods and being paid.

Cash cycleDays to pay suppliersDays to be paid
Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Cash cycle50302527
Days to pay suppliers69414961
Days to be paid8958

Per share, from Q3 FY26

Since Q3 FY26, per share: free cash flow has grown 11.9%; revenue has fallen 0.0%.

Free cash flowRevenue
Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Free cash flow1.0×0.9×1.0×1.1×
Revenue1.0×1.0×1.0×1.0×
Jul '26 Apr '26 Jan '26 Oct '25 Older periods
P/E ratio
5.24 5.46 7.06 7.53

+8 more quarters

P/S ratio
0.56 0.54 0.63 0.68
P/FCF ratio
3.86 4.22 5.29 5.25
P/Operating CF
56.17 16.01 5.27 62.73
P/B ratio
0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
0.95 0.96 1.04 1.22
EV/EBITDA
4.72 4.99 5.48 6.13
EV/Operating CF
5.39 6.03 6.86 7.62
EV/FCF
6.55 7.54 8.66 9.41
Quick Ratio
0.56 0.67 0.71 0.26
Current Ratio
1.20 1.38 1.27 1.21
Net Debt/EBITDA
10.25 9.57 4.44 16.31
Debt/Assets
70.09% 72.80% 76.78% 77.97%
Debt/Equity
(3.43) (3.19) (3.04) (2.44)
Asset Turnover
1.45 1.47 1.47 1.47
Operating CF/Net income
0.61 1.33 2.18 1.04
Capex/Depreciation
(0.83) (0.67) (1.00) (1.14)
Interest Coverage
3.43 3.35 8.68 2.37
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
31.44% 25.83% 23.72% 31.18%
Intangible Assets out of Total Assets
0.15 0.16 0.16 0.16
Share Based Compensation of Revenue
0.13% 0.58% 0.22% 0.44%
Graham Net Nets
(1.03) (1.07) (0.94) (0.94)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
19.09% 18.31% 14.16% 13.28%
Free Cash Flow Yield
25.91% 23.70% 18.89% 19.03%
Revenue per Share
7.53 6.86 13.10 7.78
Operating CF per Share
0.36 1.21 4.22 0.39
Capex per Share
(0.24) (0.20) (0.30) (0.35)
Free Cash Flow per Share
0.11 1.01 3.91 0.04
Cash per Share
3.95 4.08 4.58 1.15
Shareholders Equity per Share
(5.24) (5.63) (6.15) (7.77)
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
(5.24) (5.63) (6.15) (7.77)
Free Cash Flow
23.00 203.00 814.00 8.00
Working Capital
343.00 522.00 428.00 328.00
Capital Expenditures
(49.00) (41.00) (63.00) (72.00)
Net Current Asset Value
(4,160.00) (4,195.00) (4,329.00) (4,700.00)
EV/EBIT
5.69 6.08 6.72 7.46
Capex to Sales
0.03 0.03 0.02 0.05
Price to Operating Income
3.35 3.40 4.11 4.16
Other line items
Average Receivables
142.50 100.50 192.50 184.50
Average Payables
621.50 504.50 401.50 645.50
Average Inventory
930.00 825.50 716.50 1,214.50
Average Assets
4,985.00 4,922.00 4,970.50 4,986.50
Average Common Equity
(1,300.50) (1,290.50) (1,331.00) (1,670.00)

Fold the line items

Columns are period end dates